Product Details

Apo-Fluoxetine

Fluoxetine HCl
20 mg/5 mL
Oral Solution


DIN/PIN/NPN

02231328

Manufacturer

Apotex Inc.

Formulary Listing Date

2018-04-30  

Unit Price

0.3084

Amount MOH Pays

0.3084

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Fluoxetine HCl: Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.

ATC Code

N06AB03

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
01917021 Prozac NA NA
02459361 Odan-Fluoxetine 0.3084 0.3084
02231328 Apo-Fluoxetine 0.3084 0.3084
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph